
A new study reveals that oral supplementation with vitamin D positively impacts Tuberculosis Spondylitis patients. The research found significant increases in vitamin D, TLR-2, and TLR-4 levels at weeks 4 and 8 in groups receiving 10,000 IU and 5000 IU doses, while the control group showed no significant change. The conclusion suggests that vitamin D supplementation, especially at 10,000 IU/day for 8 weeks, can boost vitamin D levels and act as an immunomodulator, potentially benefiting those with skeletal tuberculosis.
Like
Save
Share